Mid cap
TVS SCS bets on defense supply chains with Italian JV
The 51:49 joint venture targets ₹2,000 crore in cumulative revenue by 2031, opening a high-margin vertical for the logistics firm.
Suven's Alzheimer's drug passes a critical Phase 3 safety check.
An independent board reviewed halfway data and told Suven to press on without changing the trial design or size. Enrollment is now at 88%.
Atlanta lands ₹285 cr power-transformer order from Punjab utility PSTCL
The order for 23 transformers is worth 15.4% of last year's revenue. It's the biggest single win from a repeat client since 2018.
ISGEC's Q4 transcript adds nothing to its prior summary
A routine record of a call already summarized; no new financials or guidance were introduced.
Gabriel India files its Q4 concall transcript. It adds nothing.
A routine filing. The written record of the May 28 call contains no new numbers or guidance.
IMFA's earnings transcript adds nothing new to the Kalinganagar story.
The May 27 call transcript is a regulatory record. Management's prior summary of integration and capacity targets stands.
Yatharth Hospital sees 36% revenue jump, buys 250 beds in Gurugram
Q4 FY26 revenue hit ₹1,207 cr, up 36% YoY, with new Delhi and Faridabad facilities now contributing 11% of group sales. The company is acquiring a 250-bed hospital in Gurugram.
SJS Enterprises lands its first ESG rating—and it's the highest CARE offers
A top-tier CareEdge-ESG 1 score puts the mid-cap decal maker on the radar for funds that filter by ESG credentials.
Titagarh's Q4 call transcript is a record, not a signal
The June 1 filing is a verbatim transcript of the live earnings call. It contains no new data, orders, or strategic shifts beyond what was already disclosed.
Indiabulls to raise ₹1,000 cr from promoters and funds via convertible warrants
The ₹19.40-a-share warrant issue, convertible in 18 months, will dilute shareholders by 19.3% of current market cap. Promoters Hermes and Phanes are in.
Time Technoplast pushes back debt-free target, expands asset sale plan
The 15% volume growth and 21% profit guidance for FY27 comes with a longer deleveraging timeline.
Niva Bupa's chairman exits on health grounds; ex-SBI MD to replace him
Milind Barve steps down effective June 2026. The board has named former SEBI member Ashwani Bhatia as his successor, pending shareholder and IRDAI approval.
Finolex's Q4 earnings call transcript adds nothing new to a known story
The formal record of the May 27 call confirms the already-released numbers: ₹332 crore EBITDA and a sub-15% margin guide for FY27. No surprises.
Marksans plans ₹4,000 cr revenue by FY28, but the call transcript adds nothing new
The earnings call transcript is a record of guidance already given. Management targets ₹4,000 crore revenue by FY28 and says the heavy capex cycle is over.
Diamond Power adds 150 km of monthly cable capacity for ₹30 cr
The eighth line at Vadodara is a small spend that lifts total output by 14% to back a multi-thousand-crore order book.
Relaxo's transcript adds nothing to a story the market already read
The Q4 and FY26 call transcript is a verbatim record of the prior results announcement. No new data emerged.
Travel Food Services posts Q4 call transcript. Nothing new inside.
The formal record of a call the market already heard. It confirms, but does not advance.
Granules India's US unit gets FDA inspection report with four open observations
The Chantilly, Virginia plant closed its FDA review with a Voluntary Action Indicated classification, but four observations remain open for resolution.
Varroc signs Tolyy deal to build digital cockpits in India
The partnership lets Varroc localize display manufacturing for global vehicle platforms, but project-specific fees and volumes remain to be negotiated.
Finolex's EHV JV turns ₹21 cr profit, but optical fiber payoff waits until FY27
Core electrical revenue grew 22% in Q4 FY26. A ₹300 cr capex plan is underway, but the optical fiber expansion won't contribute until the second half of FY27.
Power Mech lands ₹266 cr Adani contract to run its thermal plant
A five-year, recurring mandate from Adani Group. It's worth 3.4% of Power Mech's market cap.
CleanMax lands its biggest group captive deal, a 160 MW hybrid for Gujarat Alkalies
The mid-cap renewable player locks in a long-term, high-volume offtake with a government-promoted chemical maker.
Unimech order book doubles, Q1 to beat Q4 on nuclear and Saudi wins
The ₹314 crore order book is more than double the prior level, with a ₹450 crore acquisition and ₹87 crore in new nuclear contracts providing the lift.
Shilpa Medicare buys 30% of Spanish biotech for €7M, chases a brain-cancer therapy
Its unit Shilpa Biocare acquires a minority stake in Gate2Brain, gaining manufacturing rights for a candidate with orphan drug status from the FDA and EMA.
ASM Technologies to raise funds after two acquisitions but discloses no terms
The board will weigh capital-raising options next week. The company has not said how much money it needs or what it will cost existing shareholders.